Atlas Trials

Multiple Sclerosis, Primary Progressive

29 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Multiple Sclerosis, Primary Progressive

RecordFirmDate
Exercise Effects in Multiple Sclerosis (NCT05496881)University of Regina2022-06-15
Neuroprotection With N-acetyl Cysteine for Patients With Progressive Multiple Sclerosis (NCT05122559)Emmanuelle Waubant, MD PhD2022-02-16
MS-ResearchBiomarkerS (NCT05204459)Cedars-Sinai Medical Center2021-11-11
A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Ocrelizumab in Adult Participants With Primary Progressive Multiple Sclerosis (NCT04544449)Hoffmann-La Roche2020-10-26
A Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis (NCT04035005)Hoffmann-La Roche2019-08-12
Improving Cognition in People With Progressive Multiple Sclerosis Using Aerobic Exercise and Cognitive Rehabilitation (NCT03679468)Sunnybrook Health Sciences Centre2019-03-18
Cognition Evolution and MRI Markers in PPMS Patients on 2 Years (NCT03455582)University Hospital, Bordeaux2018-09-24
Follow-up Study of the Effectiveness of Virtual Reality Therapy in MS Patients (NCT04550650)Somogy Megyei Kaposi Mór Teaching Hospital2018-04-06
The Effect of Neurorehabilitation Therapy on Postural Control, Mobility and Quality of Life in Multiple Sclerosis Patients (NCT03424538)Somogy Megyei Kaposi Mór Teaching Hospital2018-02-05
Hydroxychloroquine in Primary Progressive Multiple Sclerosis (NCT02913157)University of Calgary2016-11-01
Study to Explore the Mechanism of Action of Ocrelizumab and B-Cell Biology in Participants With Relapsing Multiple Sclerosis (RMS) or Primary Progressive Multiple Sclerosis (PPMS) (NCT02688985)Genentech, Inc.2016-04-29
Open-label Study of Liothyronine in MS (NCT02506751)Johns Hopkins University2015-07-01
Aerobic Exercises for Multiple Sclerosis (NCT04545372)South Valley University2015-02-02
A Safety and Efficacy Study of Oral Prolonged-Release Fampridine (BIIB041) in Japanese Participants With Multiple Sclerosis (NCT01917019)Biogen2013-08-01
Imaging of Intracerebral Inflammation in MS (NCT02305264)Assistance Publique - Hôpitaux de Paris2012-03-19
Efficacy and Safety of Masitinib in the Treatment of Progressive Multiple Sclerosis (NCT01433497)AB Science2011-08-01
A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis (NCT01194570)Hoffmann-La Roche2011-03-02

Track Multiple Sclerosis, Primary Progressive automatically

Every clearance here is in the API, with alerts when new ones post.